WesBanco Bank’s Axsome Therapeutics AXSM Stock Holding History

WesBanco Bank’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.15M	Sell	8,800 -2,000	-19%	-$434K	0.05%	248
2026 Q1	$1.83M	Buy	10,800 +2,000	+23%	+$345K	0.05%	256
2025 Q4	$1.61M	Sell	8,800 -4,500	-34%	-$628K	0.04%	279
2025 Q3	$1.62M	Hold	13,300	–	–	0.04%	281
2025 Q2	$1.39M	Hold	13,300	–	–	0.04%	300
2025 Q1	$1.55M	Hold	13,300	–	–	0.05%	245
2024 Q4	$1.13M	Hold	13,300	–	–	0.04%	299
2024 Q3	$1.2M	Hold	13,300	–	–	0.04%	290
2024 Q2	$1.07M	Buy	13,300 +5,000	+60%	+$370K	0.04%	284
2024 Q1	$662K	Buy	+8,300	New	+$697K	0.03%	369

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

WesBanco Bank's AXSM Position: Q2 2026 in Review

WesBanco Bank reduced its Axsome Therapeutics (AXSM) stake by 19% in Q2 2026, selling an estimated $434K and leaving 8,800 shares worth $2.15M. The position accounts for 0.05% of the portfolio, ranked #248.

WesBanco Bank first reported a position in AXSM in Q1 2024 and has held it in 10 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

WesBanco Bank held 8,800 shares of Axsome Therapeutics worth $2.15M as of Q2 2026.
WesBanco Bank sold 2,000 Axsome Therapeutics shares in Q2 2026, an estimated $434K.
Axsome Therapeutics made up 0.05% of WesBanco Bank's portfolio in Q2 2026, its #248 holding.
WesBanco Bank first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 10 quarters since.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.